AHR and ovarian carcinoma: In support of the role of AhR in cancer development, researchers have identified upregulated expression of AhR in human and rodent tumors, such as breast cancer [125–127], lung adenocarcinoma [128, 129], and ovarian cancer [130], implicating the role of AhR in tumor progression.